Cough, Cold and Allergy (Hay Fever) Remedies in Argentina

Abstract
Cough, cold and allergy (hay fever) remedies retail value sales recovered as the COVID-19 vaccine programme ended at the end of 2021. Moreover, as normal activities resumed, with people returning to work, school, and socialising, and as masks were removed and social distancing became less stringent, people became more reacquainted with germs of colds, influenza, and other respiratory ailments.

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Argentina report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Cough, Cold and Allergy (Hay Fever) Remedies in Argentina

List Of Contents And Tables

COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN ARGENTINA
KEY DATA FINDINGS
2022 DEVELOPMENTS
Cough, cold remedies recover as normal lifestyles resume after the pandemic
Restarting normal lifestyles help allergy remedies to rebound in 2022
Arcor and Mondelez maintain leads, while Procter & Gamble rides strong growth with its Vick portfolio
PROSPECTS AND OPPORTUNITIES
Consumption set to grow further as consumers return to outdoor lifestyles, although seasonality remains a key factor
Cetirizine likely to help drive antihistamines/allergy remedies (systemic) sales over the forecast period
Medicated confectionery to benefit from an emphasis on sugar-free products
CATEGORY DATA
Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN ARGENTINA
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 8 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2017-2022
Table 10 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 11 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 12 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 13 Distribution of Consumer Health by Format: % Value 2017-2022
Table 14 Distribution of Consumer Health by Format and Category: % Value 2022
Table 15 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources